There’s new evidence that mind-body interventions can help reduce pain in people who have been taking prescription opioids — and lead to reductions in the drug’s dose.
Marie-Josée Ménard, a teacher in Montreal, started experiencing symptoms of ME/CFS in 2010. At the time, her doctor concluded it was severe depression.
A network of Canadian scientists is trying to make up for lost time in the search for a standard diagnostic test and treatment for a debilitating, poorly understood disease that had long been dismissed as a psychological illness.
Hilda Bastian writes about the recent much anticipated change of conclusion to the Cochrane Review on Exercise and CFS.
The Third Annual Community Symposium on the Molecular Basis of ME/CFS, sponsored by OMF, took place on September 7, 2019 at Stanford University. It brought together hundreds of researchers, clinicians, patients, caregivers, families, and advocates, and thousands more by livestream.
The state of ME/CFS research in Australia and awareness are the subjects of this excellent article by Amanda Cox.
The Metabolic Trap could be caused by a IDO2 mutation found in ME patients, Dr. Davis discusses the possible implications of this research.
A great review of recent research around ME/CFS by Dr. Henry Miller, Senior Fellow at the Pacific Research Institute.
Dr. Mike Snyder demonstrates how big data and wearable technology can lead to better health.
Dr. Juan Santiago presents his fascinating work on developing an ME/CFS bio-marker from observed Red Blood Cell Deformability.
Dr. Robert Phair presents an update on his theories and findings around Metabolic Trap research.